Treatment of severe botulism with 3,4-diaminopyridine;Traitement d'un botulisme grave par la 3,4-diaminopyridine

Presse Medicale

Volumn 31, Issue 13, 2002, Pages 601-602

  Dock, M ^a   Ali, A Ben ^a   Karras, A ^a   Misset, B ^a   Garrouste Orgeas, Maïté ^a   Deletie, E ^a   Goldstein, E ^a   Carlet, J ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; BOTULINUM TOXIN B;

ACETYLCHOLINE RELEASE; AGED; ARTICLE; ARTIFICIAL VENTILATION; AUTONOMIC NERVOUS SYSTEM; BOTULISM; CASE REPORT; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SPECIFICITY; ENDOTRACHEAL INTUBATION; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; NEUROMUSCULAR JUNCTION DISORDER; SERODIAGNOSIS;

4-AMINOPYRIDINE; ACETYLCHOLINE; AGED; BOTULINUM TOXINS; BOTULISM; FEMALE; FOOD POISONING; HUMANS; NEUROMUSCULAR JUNCTION; TREATMENT OUTCOME;

EID: 0037029339     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Le botulisme en France en 1997
2. Botulism in the United States: A clinical and epidemiologic review
3. A randomized trial of 2,3-diaminopyridine in Lambert-Eaton myasthenic syndrome
4. Effect of 3,4-Diaminopyridine on the Survival of Mice injected with Botulinum Neurotoxin type A, B, E or F
5. Infections toxiniques: Diphtérie, tétanos et botulisme
6. Toxines clostridiales et synapses
7. Botulinum toxin: A deadly poison sheds its negative image